Published in J Clin Invest on October 15, 1996
The role of infections in autoimmune disease. Clin Exp Immunol (2009) 1.47
Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity. Infect Immun (2004) 1.33
Cardiac involvement with parasitic infections. Clin Microbiol Rev (2010) 1.32
Chagas heart disease pathogenesis: one mechanism or many? Curr Mol Med (2008) 1.26
Chagas' disease and the autoimmunity hypothesis. Clin Microbiol Rev (1999) 1.18
Gamma interferon modulates CD95 (Fas) and CD95 ligand (Fas-L) expression and nitric oxide-induced apoptosis during the acute phase of Trypanosoma cruzi infection: a possible role in immune response control. Infect Immun (1999) 1.17
Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease. Mem Inst Oswaldo Cruz (2009) 1.11
Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase. Infect Immun (1999) 1.07
Phenotypic and functional characteristics of CD28+ and CD28- cells from chagasic patients: distinct repertoire and cytokine expression. Clin Exp Immunol (2004) 1.04
Pathology affects different organs in two mouse strains chronically infected by a Trypanosoma cruzi clone: a model for genetic studies of Chagas' disease. Infect Immun (2004) 1.03
Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10. PLoS Negl Trop Dis (2012) 1.00
Cardiac myosin autoimmunity in acute Chagas' heart disease. Infect Immun (2001) 1.00
Modulation of autoimmunity by treatment of an infectious disease. Infect Immun (2007) 0.98
Modulation of chagasic cardiomyopathy by interleukin-4: dissociation between inflammation and tissue parasitism. Am J Pathol (2001) 0.97
Heat-killed Trypanosoma cruzi induces acute cardiac damage and polyantigenic autoimmunity. PLoS One (2011) 0.97
A cardiac myosin-specific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect Immun (2004) 0.97
Profile of central and effector memory T cells in the progression of chronic human chagas disease. PLoS Negl Trop Dis (2009) 0.96
Autoimmune pathogenesis of Chagas heart disease: looking back, looking ahead. Am J Pathol (2015) 0.90
Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity. Autoimmunity (2008) 0.87
Antigenicity of Leishmania braziliensis histone H1 during cutaneous leishmaniasis: localization of antigenic determinants. Clin Diagn Lab Immunol (2002) 0.85
Relevance of molecular mimicry in the mediation of infectious myocarditis. J Cardiovasc Transl Res (2013) 0.83
Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease. Clin Exp Immunol (2001) 0.83
The heart of the matter: protection of the myocardium from T cells. J Autoimmun (2013) 0.79
Induction of IL-12 production in human peripheral monocytes by Trypanosoma cruzi Is mediated by glycosylphosphatidylinositol-anchored mucin-like glycoproteins and potentiated by IFN- γ and CD40-CD40L interactions. Mediators Inflamm (2014) 0.78
Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy. Cell Microbiol (2016) 0.78
Role of impaired central tolerance to α-myosin in inflammatory heart disease. Trends Cardiovasc Med (2012) 0.78
Highly conserved CDR3 region in circulating CD4(+)Vβ5(+) T cells may be associated with cytotoxic activity in Chagas disease. Clin Exp Immunol (2012) 0.77
Human leucocyte antigen-G (HLA-G) and its murine functional homolog Qa2 in the Trypanosoma cruzi Infection. Mediators Inflamm (2015) 0.75
Autoimmune disease triggered by infection with alphaproteobacteria. Expert Rev Clin Immunol (2009) 0.75
Galectin-1: a biomarker of surgical stress in murine model of cardiac surgery. Int J Clin Exp Pathol (2015) 0.75
Decreased level of antibodies and cardiac involvement in patients with chronic Chagas heart disease vaccinated with BCG. Med Microbiol Immunol (2013) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Preparation of myosin and its subfragments from rabbit skeletal muscle. Methods Enzymol (1982) 6.29
Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today (1993) 3.81
Autoimmunity in chagas disease cardiomyopathy: Fulfilling the criteria at last? Parasitol Today (1996) 3.60
Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol (1987) 2.65
Myosin. Annu Rev Biochem (1984) 2.37
Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis. J Immunol (1987) 2.28
Myosin-induced acute myocarditis is a T cell-mediated disease. J Immunol (1991) 2.20
Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas' heart disease. Am J Trop Med Hyg (1989) 2.15
Sequence of myosin-crossreactive epitopes of streptococcal M protein. J Exp Med (1986) 1.43
Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation (1995) 1.36
Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc Natl Acad Sci U S A (1991) 1.33
Intrathyroidal T cell clones from patients with autoimmune thyroid disease. J Clin Endocrinol Metab (1987) 1.29
Use of recombinant antigens for the accurate immunodiagnosis of Chagas' disease. Am J Trop Med Hyg (1992) 1.22
Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med (1992) 1.20
The use of nitrocellulose immunoblots for the analysis of antigen recognition by T lymphocytes. J Immunol Methods (1988) 1.17
Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol (1993) 1.17
Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas' disease. Exp Parasitol (1993) 1.16
Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci U S A (1995) 1.15
Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc Natl Acad Sci U S A (1992) 1.09
Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanosoma cruzi-infected mice. J Immunol (1994) 1.02
Cell surface antigens of Trypanosoma cruzi: possible correlation with the interiorization process in mammalian cells. Mol Biochem Parasitol (1982) 1.01
Clonal analysis of liver-infiltrating T cells in patients with LKM-1 antibody-positive autoimmune chronic active hepatitis. Clin Exp Immunol (1991) 0.99
Autoimmunity in Chagas' disease: specific inhibition of reactivity of CD4+ T cells against myosin in mice chronically infected with Trypanosoma cruzi. Infect Immun (1989) 0.98
T-cell recognition of bacterial heat-shock proteins in inflammatory arthritis. Immunol Rev (1991) 0.95
Lymphocyte growth from cardiac allograft biopsy specimens with no or minimal cellular infiltrates: association with subsequent rejection episode. J Heart Transplant (1989) 0.95
Maintenance of antigen specificity by human interleukin-2-dependent T cell lines. Use of antigen-presenting cells and OKT3 antibody in the absence of antigen. J Clin Invest (1985) 0.89
Trypanocidal nitroarene treatment of experimental Trypanosoma cruzi infection does not prevent progression of chronic-phase heart lesions in rabbits. J Infect Dis (1990) 0.85
Restricted heterogeneity of T cell receptor variable alpha chain transcripts in hearts of Chagas' disease cardiomyopathy patients. Parasite Immunol (1994) 0.84
Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet (1996) 2.29
Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor alpha polymorphisms at position -308. J Hepatol (2001) 1.46
Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun (2001) 1.39
Human heart-infiltrating T-cell clones from rheumatic heart disease patients recognize both streptococcal and cardiac proteins. Circulation (1995) 1.36
HLA class I genes integrated into murine cells are inducible by interferon. Eur J Immunol (1983) 1.27
Rheumatic fever and rheumatic heart disease: genetics and pathogenesis. Scand J Immunol (2007) 1.26
Genes, autoimmunity and pathogenesis of rheumatic heart disease. Ann Pediatr Cardiol (2011) 1.17
Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol (1993) 1.17
Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci U S A (1995) 1.15
T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients. Infect Immun (2001) 1.11
The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies. Clin Cardiol (1987) 1.11
Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2. Am J Gastroenterol (1999) 1.06
Right ventricular endomyocardial biopsy in chronic Chagas' disease. Am Heart J (1986) 1.05
Rheumatic heart disease: mediation by complex immune events. Adv Clin Chem (2011) 1.01
Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+ T cells at heart lesions of human chronic Chagas disease cardiomyopathy. Scand J Immunol (2007) 0.99
HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol (1998) 0.98
Monoclonal antibodies as a tool for phylogenetic studies of major histocompatibility antigens and beta 2-microglobulin. Immunogenetics (1982) 0.98
Antibodies eluted from acutely rejected renal allografts bind to and activate human endothelial cells. Hum Immunol (2000) 0.98
Molecular analysis of HLA DR4-beta 1 gene in malaria vaccinees. Typing and subtyping by PCR technique and oligonucleotides. Parasite Immunol (1991) 0.98
Molecular evidence for antigen-driven immune responses in cardiac lesions of rheumatic heart disease patients. Int Immunol (2000) 0.97
Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high-grade myocarditis. Ann Trop Med Parasitol (2008) 0.96
Influence of HLA class I- and class II-specific monoclonal antibodies on DR-restricted lymphoproliferative responses. I. Unseparated populations of effector cells. J Immunol (1983) 0.95
HLA monoclonal antibody registry: a proposal. Tissue Antigens (1982) 0.94
A vaccine against S. pyogenes: design and experimental immune response. Methods (2009) 0.94
Towards a vaccine against rheumatic fever. Clin Dev Immunol (2006) 0.94
Allergic asthma in patients with common variable immunodeficiency. Allergy (2009) 0.94
The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. Ann Thorac Surg (2001) 0.94
Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz J Med Biol Res (1998) 0.93
Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy. Autoimmunity (2001) 0.92
Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol (1995) 0.92
Heart infiltrating T cell clones from a rheumatic heart disease patient display a common TCR usage and a degenerate antigen recognition pattern. Mol Immunol (2004) 0.91
Bacterial triggers and autoimmune rheumatic diseases. Clin Exp Rheumatol (2008) 0.91
Immune response to vaccination with DNA-Hsp65 in a phase I clinical trial with head and neck cancer patients. Cancer Gene Ther (2009) 0.91
Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck. Cancer Gene Ther (2008) 0.90
HLA and beta-myosin heavy chain do not influence susceptibility to Chagas disease cardiomyopathy. Microbes Infect (2000) 0.90
Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation (1991) 0.88
Identification of paramyosin T cell epitopes associated with human resistance to Schistosoma mansoni reinfection. Clin Exp Immunol (2005) 0.87
Identification of a viral antigen recognized by H-2-restricted cytolytic T lymphocytes on a murine leukemia virus-induced tumor. J Immunol (1983) 0.87
Association of air-conditioning with respiratory symptoms in office workers in tropical climate. Indoor Air (2005) 0.87
Extensive polymorphism of a (CA)n microsatellite located in the HLA-DQA1/DQB1 class II region. Hum Immunol (1995) 0.86
Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells. Mem Inst Oswaldo Cruz (2004) 0.86
HLA-DRB1*04:02, DRB1*08:04 and DRB1*14 alleles associated to pemphigus vulgaris in southeastern Brazilian population. Tissue Antigens (2011) 0.86
How an autoimmune reaction triggered by molecular mimicry between streptococcal M protein and cardiac tissue proteins leads to heart lesions in rheumatic heart disease. J Autoimmun (2005) 0.85
[Presence of 2 different epitopes on the human beta 2-microglobulin defined by monoclonal antibodies]. Ann Immunol (Paris) (1983) 0.85
Heart transplantation for chronic Chagas' heart disease. Ann Thorac Surg (1996) 0.85
Identification of patients at high risk of graft loss by pre- and posttransplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay. Transplantation (1997) 0.85
Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus. Hum Immunol (2001) 0.85
Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome. Rheumatology (Oxford) (2006) 0.85
Cellular autoreactivity against heat shock protein 60 in renal transplant patients: peripheral and graft-infiltrating responses. Clin Exp Immunol (2006) 0.84
Restricted heterogeneity of T cell receptor variable alpha chain transcripts in hearts of Chagas' disease cardiomyopathy patients. Parasite Immunol (1994) 0.84
Immunological tolerance in human transplantation. The possible existence of a maternal effect. Transplantation (1990) 0.84
[Implantation of a Starr-Edwards prosthesis lasting more than 15 years. Analysis of 34 cases]. Arq Bras Cardiol (1987) 0.83
[Hemodynamic and neurohormonal profile during assisted circulation with heterotopic artificial ventricle followed by heart transplantation]. Arq Bras Cardiol (1994) 0.83
HLA class II antigens in rheumatic fever. Analysis of the DR locus by restriction fragment-length polymorphism and oligotyping. Hum Immunol (1994) 0.83
HLA monoclonal antibody registry: second listing. Tissue Antigens (1983) 0.83
Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects. Br J Radiol (2013) 0.83
Investigation of the ZFY gene in XX true hermaphroditism and Swyer syndrome. Hum Genet (1990) 0.83
Heart-directed autoimmunity: the case of rheumatic fever. J Autoimmun (2001) 0.83
Proteomic inventory of myocardial proteins from patients with chronic Chagas' cardiomyopathy. Braz J Med Biol Res (2006) 0.82
Role of class I and class II antigens in the allogenic stimulation: class I and class II recognition in allogenic stimulation; blocking of MLR by monoclonal antibodies and F(ab')2 fragments. Cell Immunol (1983) 0.82
The Brazilian experience with heart transplantation: a multicenter report. J Heart Lung Transplant (2001) 0.82
[Effects of partial ventriculectomy on left ventricular mechanical properties, shape, and geometry in patients with dilated cardiomyopathy]. Arq Bras Cardiol (1996) 0.82
Rheumatic Fever. Images Paediatr Cardiol (2002) 0.81
Persistent allergic rhinitis and indoor air quality perception--an experimental approach. Indoor Air (2006) 0.80
Left ventricular regional wall motion, ejection fraction, and geometry after partial left ventriculectomy. Influence of associated mitral valve repair. Eur J Cardiothorac Surg (2000) 0.80
Severe bilateral necrotising retinitis caused by Toxoplasma gondii in a patient with systemic lupus erythematosus and diabetes mellitus. Br J Ophthalmol (2003) 0.80
Long-term follow-up after heart transplantation in Chagas' disease. Transplant Proc (1993) 0.80
Assisted circulation with an auxiliary heart transplant. An experimental study. J Thorac Cardiovasc Surg (1972) 0.80
Humoral rejection in two HLA identical living related donor kidney transplants. Transplant Proc (1989) 0.80
Different HLA profiles confer susceptibility to autoimmune hepatitis type 1 and 2. Am J Gastroenterol (1998) 0.80
Cytomegalovirus infection amplifies class I major histocompatibility complex expression on cultured human endothelial cells. J Heart Lung Transplant (1994) 0.80
Familial amyloidotic polyneuropathy type 1 in Brazil is associated with the transthyretin Val30Met variant. Amyloid (1999) 0.80
Predominant IL-10 production in indirect alloreactivity is not associated with rejection. Clin Immunol (2001) 0.79
Treatment with encapsulated Hsp60 peptide (p277) prolongs skin graft survival in a murine model of minor antigen disparity. Scand J Immunol (2007) 0.79
DQB1-0602 (DQw1) is not present in most nonDR2 Caucasian narcoleptics. Sleep (1992) 0.79
Pretransplant rejection risk assessment through enzyme-linked immunosorbent assay analysis of anti-HLA class I antibodies. Am J Kidney Dis (1996) 0.79